WallStSmart
NAUT

Nautilus Biotechnology Inc

NASDAQ: NAUT · HEALTHCARE · BIOTECHNOLOGY

$2.93
-10.82% today

Updated 2026-06-05

Market cap
$347.56M
P/E ratio
P/S ratio
EPS (TTM)
$-0.46
Dividend yield
52W range
$1 – $4
Volume
0.4M

Nautilus Biotechnology Inc (NAUT) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20182019202020212022202320242025
Revenue$0.00$0.00$0.00$0.00$0.00$0.00
Revenue growth (YoY)
Cost of revenue$2.35M$2.84M$3.42M$5.71M$6.35M$6.46M
Gross profit$-2.35M$-2.84M$-3.42M$-5.71M$-6.35M$-6.46M
Gross margin
R&D$8.49M$10.09M$26.51M$36.45M$47.25M$50.48M$41.11M
SG&A$111.68M$1.62M$3.31M$21.15M$25.95M$28.90M$31.00M$25.73M
Operating income$-111.68M$-10.11M$-15.74M$-50.50M$-63.62M$-76.15M$-81.48M$-66.84M
Operating margin
EBITDA$626.60M$-9.56M$-13.27M$-47.47M$-54.51M$-74.30M$-64.43M$-52.54M
EBITDA margin
EBIT$-111.68M$-10.11M$-15.62M$-50.31M$-57.92M$-76.15M$-70.78M$-59.00M
Interest expense$0.00$0.00$0.00$183000.00$5.82M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$626.60M$-9.62M$-15.62M$-50.31M$-57.92M$-63.67M$-70.78M$-59.00M
Net income growth (YoY)-101.5%-62.4%-222.1%-15.1%-9.9%-11.2%+16.6%
Profit margin

Frequently asked questions

How much free cash flow does NAUT generate?

NAUT produced $-51.97M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is NAUT's balance sheet healthy?

NAUT holds $12.39M in cash and equivalents against — in long-term debt, on $156.97M of shareholder equity. That debt is best read against the cash flow the business throws off each year.